Sort by
Refine Your Search
-
: Exempt Work Schedule: Monday – Friday, 8 a.m. – 5 p.m. Summary The postdoctoral associate will focus on data collection and management of clinical projects on aortic disease research. The ideal candidate
-
. Analyzes large data sets. Analyzes next generation sequencing data (e.g., RNS-seq, whole genome/exome sequencing). Uses state-of-the-art bioinformatical and statistical tools. Develops new statistical
-
: Monday – Friday, 8 a.m. – 5 p.m. Summary The postdoctoral associate will focus on data collection and management of clinical projects on aortic disease research. The ideal candidate must have an MD or PhD
-
for clinical research, focusing on malignancies including breast and lung cancer and intraoperative studies. Job Duties Develops, implements and manages computational workflows and data analysis pipelines
-
cancer and intraoperative studies. Job Duties Develops, implements and manages computational workflows and data analysis pipelines for processing and interpreting mass spectrometry and mass spectrometry
-
: Exempt Work Schedule: Monday – Friday, 8 a.m. – 5 p.m. Summary The postdoctoral associate will focus on data collection and management of clinical projects on aortic disease research. The ideal candidate
-
mammalian brain development, and how abnormalities in normal brain development lead to the development of brain cancers. Analyzes and interprets data (whole-genome, whole-exome, ChIP-seq and RNAseq) in light
-
activities. The Postdoctoral Associate will assist in evaluating and analyzing data collected from research staff for new clinical research protocols. Job Duties Conducts activities that may include treatment
-
experiments, analyzes data, and prepares publications describing results. Helps in training and mentoring of lab personnel, including graduate and undergraduate students. Maintains good communication with lab
-
enormous genetic information to functional information). We place emphasis in "Translational Research": from “discovering mechanisms” to “developing innovative treatment strategies” to “moving into clinical